Abu dhabi: Burjeel Holdings today announced its unaudited preliminary financial results for the year ended December 31, 2025. Burjeel Holdings reported a significant net profit growth of 39.5% year-on-year, reaching AED 503 million, with a notable improvement in the net margin to 9.1%. The company delivered a robust revenue of AED 5,501 million, marking a 9.8% increase compared to the previous year, while total patient visits exceeded 7 million, growing by 8.4%.
According to Emirates News Agency, the growth was driven by deeper community reach through specialized products and services aligned with local market demand. This was supported by disciplined execution and the continued ramp-up of newly launched facilities. EBITDA saw a 19.9% year-on-year increase, reaching AED 1,089 million, with the margin expanding to 19.8% from 18.1% in 2024. The improvements were attributed to efficient workforce planning, stronger procurement discipline, optimized supplier terms, and tighter overhead control, alongside asset ownership optimization and rising operating leverage.
Inpatient volumes grew by 11.7% in 2025, showing strong demand across key specialties such as oncology, cardiology, gastroenterology, and orthopedics. Over 89,700 surgeries were performed during the year at facilities including Burjeel Medical City, Medeor Hospital Abu Dhabi, Burjeel Hospital Abu Dhabi, and Lifecare Hospital Musaffah. Outpatient footfall rose by 8.3%, supported by the expansion of the Group's ambulatory network and the establishment of new day care, medical, IVF, and physiotherapy centers.
Dr. Shamsheer Vayalil, Chairman and CEO of Burjeel Holdings, stated, "2025 was a year of strong momentum for Burjeel Holdings, driven by an integrated network and close alignment with national healthcare priorities. Investments in our ecosystem, medical leadership, and people translated into robust growth and improved earnings quality. We also expanded our footprint, scaling our community-care network in the UAE and progressing specialized care platforms in Saudi Arabia. Looking ahead, we are well positioned to deliver sustainable long-term value for shareholders while elevating access to high-quality healthcare across the markets we serve."
